|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows used in operating activities: | |||||
| Net loss | |||||
| Stock based compensation | |||||
| Amortization of intangibles | |||||
| Asset impairment | |||||
| Unrealized gain and accrued interest on investments | |||||
| Realized and unrealized gain and accrued interest on investments | |||||
| Changes in assets and liabilities: | |||||
| Increase in accounts payable and accrued expenses | |||||
| Increase (decrease) in accounts payable and accrued expenses | |||||
| Decrease in prepaid expenses and other assets | |||||
| Net cash used in operating activities | |||||
| Cash flows provided by investing activities: | |||||
| Purchase of investments | |||||
| Proceeds from redemption of investments | |||||
| Net cash used by investing activities | |||||
| Cash flows (used in) provided by financing activities: | |||||
| Payments of deferred financing costs | |||||
| Payment of amounts due to officers | |||||
| Net cash provided by financing activities | |||||
| Effect of foreign exchange rate on changes on cash | |||||
| Net change in cash and cash equivalents: | |||||
| Cash and cash equivalents - beginning of year | |||||
| Cash and cash equivalents - end of year | |||||
| Supplemental information - Non cash items: | |||||
| Offering expenses associated with warrant modification | |||||
| Accrued offering expenses included in additional paid in capital | |||||
Loading...